Mass General (MGH) — Boston, Massachusetts

Mass General (MGH) is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Mass General (MGH) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: New Onset Refractory Status Epilepticus, New-Onset Refractory Status Epilepticus, Febrile Infection-Related Epilepsy Syndrome (FIRES).

Sponsors: Yale University.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General (MGH)?

Mass General (MGH) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General (MGH) conducted?

Mass General (MGH) has 1 clinical trials on record, with 1 currently active. Their work covers New Onset Refractory Status Epilepticus, New-Onset Refractory Status Epilepticus, Febrile Infection-Related Epilepsy Syndrome (FIRES).

Is Mass General (MGH) accredited by Crixeo Health?

Mass General (MGH) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mass General (MGH)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.